Idenix Pharmaceuticals LLC et al v. Gilead Pharmasset LLC
Idenix Pharmaceuticals LLC, Universita Degli Studi di Cagliari, Centre National de la Recherche Scientifique and Universite de Montpellier |
Gilead Pharmasset LLC |
1:2015cv00416 |
May 21, 2015 |
US District Court for the District of Delaware |
Wilmington Office |
XX Outside US |
Christopher J. Burke |
Leonard P. Stark |
Patent |
35 U.S.C. ยง 0146 |
Plaintiff |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 26 MEMORANDUM ORDER re 23 REPORT AND RECOMMENDATION is ADOPTED in full. 9 MOTION to Dismiss filed by Gilead Pharmasset LLC is GRANTED and the case is DISMISSED. ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 11/16/16. (ntl) |
Filing 23 REPORT AND RECOMMENDATIONS recommending GRANTING D.I. 9 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Gilead Pharmasset LLC. Please note that when filing Objections pursuant to Federal Rule of Civil Proce dure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/22/2016. Signed by Judge Christopher J. Burke on 7/5/2016. (mlc) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.